Gene · 6385
Papers3,062
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,062
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meet. | Endocr Relat Cancer | 2023 | 37410387 | PubTator, text mining | PubMed |
| Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer. | Cancer Epidemiol Biomarkers Prev | 2023 | 37410084 | PubTator, text mining | PubMed |
| tRNA-derived RNAs: Biogenesis and roles in translational control. | Wiley Interdiscip Rev RNA | 2023 | 37406666 | PubTator, text mining | PubMed |
| Gi/o GPCRs drive the formation of actin-rich tunneling nanotubes in cancer cells via a Gβγ/PKCα/FARP1/Cdc42 axis. | J Biol Chem | 2023 | 37390986 | PubTator, text mining | PubMed |
| Tumour associated endothelial cells: origin, characteristics and role in metastasis and anti-angiogenic resistance. | Front Physiol | 2023 | 37389120 | PubTator, text mining | PubMed |
| The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction. | Cardiovasc Diabetol | 2023 | 37386461 | PubTator, text mining | PubMed |
| Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial. | Signal Transduct Target Ther | 2023 | 37385995 | PubTator, text mining | PubMed |
| Novel Histopathological Biomarkers in Prostate Cancer: Implications and Perspectives. | Biomedicines | 2023 | 37371647 | PubTator, text mining | PubMed |
| Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets. | Cancers (Basel) | 2023 | 37370735 | PubTator, text mining | PubMed |
| Engineered Biomimetic Fibrillar Fibronectin Matrices Regulate Cell Adhesion Initiation, Migration, and Proliferation via α5β1 Integrin and Syndecan-4 Crosstalk. | Adv Sci (Weinh) | 2023 | 37357136 | PubTator, text mining | PubMed |
| Weaving the nest: extracellular matrix roles in pre-metastatic niche formation. | Front Oncol | 2023 | 37350937 | PubTator, text mining | PubMed |
| CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease. | Brain | 2023 | 37348871 | PubTator, text mining | PubMed |
| GNL3 and PA2G4 as Prognostic Biomarkers in Prostate Cancer. | Cancers (Basel) | 2023 | 37345060 | PubTator, text mining | PubMed |
| Cell contractility drives mechanical memory of oral squamous cell carcinoma. | Mol Biol Cell | 2023 | 37342880 | PubTator, text mining | PubMed |
| Conformations, interactions and functions of intrinsically disordered syndecans. | Biochem Soc Trans | 2023 | 37334846 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals cell subpopulations in the tumor microenvironment contributing to hepatocellular carcinoma. | Front Cell Dev Biol | 2023 | 37333982 | PubTator, text mining | PubMed |
| Endothelial dysfunction triggers acute respiratory distress syndrome in patients with sepsis: a narrative review. | Front Med (Lausanne) | 2023 | 37332755 | PubTator, text mining | PubMed |
| Syndecan-4 proteoliposomes enhance revascularization in a rabbit hind limb ischemia model of peripheral ischemia. | Acta Biomater | 2023 | 37321528 | PubTator, text mining | PubMed |
| Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid. | Cell Death Dis | 2023 | 37308486 | PubTator, text mining | PubMed |
| Endothelial Glycocalyx Preservation-Impact of Nutrition and Lifestyle. | Nutrients | 2023 | 37299535 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6385/papers?page=18